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Abstract
Zinc enhances epithelial proliferation, protects the digestive epithelial layer and has profound antiulcerative and
antidiarrheal roles in the colon. Despite the clinical significance of this ion, the mechanisms linking zinc to these cellular
processes are poorly understood. We have previously identified an extracellular Zn
2+ sensing G-protein coupled receptor
(ZnR) that activates Ca
2+ signaling in colonocytes, but its molecular identity as well as its effects on colonocytes’ survival
remained elusive. Here, we show that Zn
2+, by activation of the ZnR, protects HT29 colonocytes from butyrate induced cell
death. Silencing of the G-protein coupled receptor GPR39 expression abolished ZnR-dependent Ca
2+ release and Zn
2+-
dependent survival of butyrate-treated colonocytes. Importantly, GPR39 also mediated ZnR-dependent upregulation of
Na
+/H
+ exchange activity as this activity was found in native colon tissue but not in tissue obtained from GPR39 knock-out
mice. Although ZnR-dependent upregulation of Na
+/H
+ exchange reduced the cellular acid load induced by butyrate, it did
not rescue HT29 cells from butyrate induced cell death. ZnR/GPR39 activation however, increased the expression of the anti-
apoptotic protein clusterin in butyrate-treated cells. Furthermore, silencing of clusterin abolished the Zn
2+-dependent
survival of HT29 cells. Altogether, our results demonstrate that extracellular Zn
2+, acting through ZnR, regulates intracellular
pH and clusterin expression thereby enhancing survival of HT29 colonocytes. Moreover, we identify GPR39 as the molecular
moiety of ZnR in HT29 and native colonocytes.
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Introduction
Colonocytes are constantly exposed to short chain fatty acids
(SCFA), produced in the colonic lumen by bacterial fermentation
of carbohydrates and dietary fibers [1]. Most prominent among
these SCFAs is butyrate, an important energy source for
colonocytes that is also regulating physiological functions such as
transepithelial ion and electrolyte transport [2,3]. Butyrate further
regulates differentiation, proliferation and cell survival of colono-
cytes, however these effects depend on the differentiation level of
the cells [4,5]. Consequently, butyrate selectively induces growth
inhibition and differentiation subsequently leading to apoptosis in
a variety of human colon cancer cell lines [6,7,8,9], but not in
normal colonocytes. Although its precise mechanism of action is
unclear, butyrate effectively regulates the expression of an array of
proteins leading to apoptosis of colon cancer cells [9,10,11,12].
Consistently, an inverse relationship is found between the level of
dietary fibers and the incidence of human colon cancer, and it has
been suggested that butyrate reduces foci number and size
[8,13,14]. In addition, changes in expression of butyrate
transporters and receptors in human cancer tissue further support
a role for this SCFA in colon cancer [15,16,17,18].
Zinc is an essential micronutrient that has an established role in
enhancing epithelial proliferation and survival [19,20,21,22],
moreover, zinc signaling is suggested to play a role in cancer
[23,24]. Zinc has been specifically shown to play a role in digestive
system function under normal conditions or stress [25,26,27].
Furthermore, zinc accelerates healing of gastric ulcers and drugs
containing zinc are commonly used to enhance colonocytes cell
proliferation and growth, although the mechanism is unknown
[25,28]. Similarly, Zn
2+ has been suggested to protect cells against
butyrate induced cell death but the cellular pathways underlying
this effect are not understood [20]. We previously identified a
Zn
2+-sensing receptor (ZnR) that is a G-protein coupled receptor.
The ZnR complexes to Gaq subunits which activate phospholi-
paseC b (PLCb). This in turn induces formation of IP3 leading to
release of intracellular Ca
2+. Using dose response analysis we
showed that ZnR is activated by Zn
2+ concentration that is
physiologically relevant in the colon, suggesting that this receptor
may be regulating the function of colonocytes [29]. In HT29
colonocytes and PC-3 prostate cancer cells, the ZnR mediates
Zn
2+-dependent activation of the MAP and PI3 kinase pathways
[21,22,30]. Desensitization of ZnR by zinc is followed by
inhibition of the Zn
2+-dependent signaling as well as proliferation
and survival of prostate cancer cells [21]. Furthermore, activation
of ZnR signaling upregulates the Na
+/H
+ exchanger (NHE) and
enhances recovery from acidic pH [22]. The molecular identity of
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(GPR39), previously thought to interact with obestatin, was shown
to interact with Zn
2+ when ectopically expressed [31,32].
Remarkably, GPR39 is expressed in the gastrointestinal tract
[31] and in the brain where ZnR activity was identified [33].
However whether GPR39 mediates Zn
2+-dependent signaling in
the colon [22,34] is unknown. Here, we find that GPR39 is the
receptor that mediates ZnR-signaling in colonocytes and elucidate
its physiological role in promoting survival of coloncytes. Our
results further indicate that extracellular Zn
2+, via GPR39
signaling, confers resistance against butyrate induced cell death
in HT29 cells.
Methods
Cell Culture
HT29-Cl cells (obtained from American Type Culture Collec-
tion) were grown in DMEM medium (Sigma-Aldrich, USA)
containing, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM
glutamine and 10% fetal calf serum (Biological Industries, Israel),
in a 5% CO2 humidified atmosphere at 37uC.
GPR39 silencing
HT29 cells were seeded in 60-mm cell culture dishes at a density
of 7610
5 cells or in 96-well plates (1.5610
4 cells) 24 h prior to
transfection in standard DMEM culture media as described above,
but without penicillin or streptomycin. Cells were transfected using
Lipofectamine 2000 according to the manufacturer protocol, and
used for the different experimental settings 48 h post transfection.
For silencing of target proteins siRNA constructs (Sigma-Aldrich,
Israel) were utilized, for GPR39: 59-CCA UGG AGU UCU ACA
GCA U-39, for CLU: 59-CCA GAG CUC GCC CUU CUA C-39
and siRNA control (scrambled) sequence was 59- GCC CAG AUC
CCU GUA CGU-39.
SRB assay for cell density
Sulforhodamine B (SRB) assay was used to assess cell survival of
HT29 cells [35]. HT29 cells were seeded into 96-well plates
(30,000 cells per well) and serum-starved for 24 h. For ZnR
activation, cells were transferred into Ringer’s solution and treated
with Zn
2+ (80 mM, 10 min) or without it (as control) and then
returned to serum-free growth media. This procedure was
repeated during 3 consecutive days, as previously described [21].
Butyrate (30 mM, pH7.4, for 24 h) was applied following the first
application of Zn
2+, and then cells were returned to serum-free
growth media. Cells were fixed after 96 hours using 10% TCA
(trichloroacetic acid) for 1 hour at 4uC. The supernatant was
discarded and plates were washed with deionized water and air-
dried. 100 ml sulforhodamine B (SRB 0.4 w/v in 1% acetic acid)
was added to each well and the culture was incubated for 10 min
at room temperature. The unbound SRB was removed by washing
with 1% acetic acid and the plates were air-dried. The dye bound
to basic amino acids of the cell membrane was solubilized with
Tris buffer (10 mM, pH 10.5) and the absorption measured at
540 nm by ELISA reader (Molecular Devices) to determine the
relative cell growth or viability in the treated as well as untreated
cells. Cell number was quantified using a calibration curve and cell
survival was determined as percentage of the number monitored in
control cells (non-treated, 100%). Each graph represents an
average of at least three independent experiments.
Real Time PCR – Real time PCR was used to estimate the
GPR39 silencing. Cells were seeded on a 60-mm plates, after
48 hours cells were trypsinized with 0.05% trypsin (Biological
Industries, Kibbutz Beit Haemek, Israel), collected. Cell lysates
were homogenized using QIAshredder as described by the
manufacturer (QIAGEN). Total RNA was purified using RNeasy
Mini Kit as described by the manufacturer (QIAGEN). 1 mg RNA
was converted to cDNA using Verso cDNA synthesis Kit as
described by the manufacturer (Thermo Scientific). cDNA was
diluted 1:16 (dilution was chosen after calibration) with ultrapure
water, and subjected to real time PCR procedure (Taqmen), which
was done with ABsolute Blue QPCR kit as described by the
manufacturer (Thermo Scientific). Primers and probes were
supplied by Solaris by the following sequences: for GPR39:
forward primer CATCTTCCTGAGGCTGA, reverse primer
ATGATCCTCCGTCTGGTTG, probe TATGCTGGATGCC-
CAAC, and for Actin: forward primer TGGAGAAAATCTGGC-
ACCAC, reverse primer GGTCTCAAACA TGATCTGG,
probe ACCGCCAGAAGATGACC.
Monitoring clusterin expression
HT29 cells were seeded on 60-mm plates (1.4610
6 cells), and
serum-starved for 24 hours. Cells were then treated daily with
Zn
2+ (80 mM for 10 min) in Ringer’s solution, in the presence or
absence of the indicated inhibitors, added 30 min prior to Zn
2+
treatment. Butyrate (30 mM, pH 7.4 in serum-free medium) was
added after the first Zn
2+ application for 24 h. Cells were
harvested following 96 h into lysis buffer (50 mM HEPES,
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10%
glycerol, 1% Triton X-100, 10 mM MgCl2, 20 mM p-nitrophenyl
phosphate, 1 mM Na3VO4, 25 mM NaF), in the presence of
Protease Inhibitor Cocktail (1:25 Complete, Roche, Germany).
Lysates were placed on ice for 10 min and then centrifuged for
30 min (14,000 rpm) at 4uC. Supernatants (cytosolic fraction) were
collected, protein concentrations were determined using Bio-Rad
protein assay, SDS sample buffer was added, and samples were
boiled for 5 min and then frozen at 280uC until used. Whole cell
lysates (50 mg) were separated on 8–10% SDS–PAGE and blotted
onto nitrocellulose membranes. The required proteins were
detected using specific antibodies raised against, a-Clusterin
(Santa-Cruz, USA) or b-actin (Cell Signaling, USA). Densitomet-
ric analysis of expression level was performed using the EZQuant-
Gel image processing and analysis software (EZQuant, Rehovot,
Israel). Clusterin levels were normalized to actin levels, and are
presented as a percentage of the maximal expression level induced
by application of Zn
2+ and butyrate. Each graph represents an
average of at least three independent experiments.
Monitoring Kinase Activation
HT29 cells were seeded on 60-mm culture dishes and serum
starved as described above. Cells were Zn
2+ treated (80 mM for
10 min) in Ringer’s solution, in the presence or absence of the
indicated inhibitors, added 30 min prior to Zn
2+ treatment (except
LY294002, added 60 min prior to Zn
2+ treatment), and incubated
for an additional 10 min after the Zn
2+ treatment to allow kinase
phosphorylation. Next, cells were harvested as described above,
whole cell lysates (50 mg) were separated on 10% SDS-PAGE and
blotted onto nitrocellulose membranes. The required proteins
were detected using specific antibodies raised against the doubly
phosphorylated ERK1/2 and total ERK1/2 or phosphorylated
AKT and total AKT. Densitometric analysis of expression level
was performed as described above. Phospho-ERK1/2 or AKT
levels were normalized against the total ERK1/2 or AKT protein,
respectively. Phosphorylation of ERK1/2 or AKT is presented as
a percentage of the effect triggered by application of 80 mMZ n
2+.
Each graph represents an average of at least three independent
experiments.
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The imaging system consisted of an Axiovert 100 inverted
microscope (Zeiss), Polychrome V monochromator (TILL Pho-
tonics, Germany) and a SensiCam cooled charge-coupled device
(PCO, Germany). Fluorescent imaging measurements were
acquired with Imaging Workbench 5 (Indec, CA). All results
shown are representative traces from one slide showing the
averaged responses of 15–25 cells. Bar graphs exhibit the mean
response of n slides (as indicated in the figure legend) taken from at
least 3 independent experiments.
Calcium imaging. For [Ca
2+]i measurements, cells were
incubated for 30 min with 2.5 mM Fura-2 acetoxymethyl ester
(AM; TEF-Lab, USA) in Ringer’s solution with 0.1% BSA. After
dye loading, the cells were washed in Ringer’s solution, and the
cover slides were mounted in a chamber that allowed the
superfusion of cells. Fura-2 was excited at 340 nm and 380 nm
and imaged with a 510 nm long-pass filter.
pH Imaging. By using the same experimental setup, HT29
cells were loaded for 12 min with 1.25 mM 2,7-bis-(carboxyethyl)-
5-(and-6)-carboxyfluorescein (BCECF)-AM (TEF-Lab, USA) in
0.1% BSA in Ringer’s solution. The excitation was at 440 nm and
480 nm, and emission was monitored through a 510 nm long-pass
filter. For pHi calibration, nigericin was added to KCl Ringer’s
(120 mM KCl replacing NaCl) solution at pH 6.8, 7 and 7.2, the
relative fluorescence was monitored, and a linear calibration curve
produced [36].
The NH4Cl prepulse paradigm was applied to estimate Na
+/H
+
exchanger activity. Briefly, cells were washed with Ringer’s
containing NH4Cl (30 mM), and an intracellular equilibrium of
NH4
+ and NH3 was reached leading to intracellular alkalinization.
Replacing the extracellular buffer with Na
+-free Ringer’s (iso-
osmotically replaced by NMG) caused rapid acidification of the
cells ad the recovery rate from this acid load following addition of
Na
+ was monitored. For monitoring cellular acidification with
butyric acid the following paradigm was employed: cells were
washed with Na
+-free Ringer’s (iso-osmotically replaced by NMG)
containing butyric acid (20 mM, pH 7.4), which caused rapid
acidification. Replacing the extracellular buffer with Na
+-contain-
ing Ringer’s resulted in pHi recovery. The Na
+/H
+ exchanger
activity was estimated by calculating the rates of recovery (dpHi/
dt) following addition of Na
+ to the Ringer’s solution in both
paradigms.
Colon tissue preparation (including Ethics Statement)
GPR39
+/+ (WT) or GPR39
2/2 (KO) littermates [37] were used
after genotyping using PCR of DNA isolated from mouse tail
biopsy samples. Primers 59- ACCCTCATCTTGGTGTACCT-39
and 59-TGTAGCGCTCAAAGCTGAG-39 amplified a 311-bp
band from the wild-type allele whereas primers 59-GGAACTCT-
CACTCGACCTGGG-39 and 59-GCAGCGCATCGCCTTC-
TATC-39 amplified a 262-bp band from the knockout allele.
Colon tissue was prepared as described previously [22,38] in
accordance with protocols approved by the committee for the
Ethical Care and Use of Animals in Research at Ben Gurion
University. Briefly, male mice at ages of 2–4 weeks, were sacrificed
and the colon removed and washed with a syringe using Parson’s
Solution. A longitudinal incision was made along the colon wall
and the tissue was immersed in the solution. Tissue samples were
cut from the distal part of the colon and were spread, keeping the
mucosal-luminal side upwards, on coverslips using cyanoacrylate
glue. Tissue samples were maintained at 37uC in high K
+ solution
for no longer than 3 h.
For the analysis of NHE activity in colon tissue the same
paradigm that was used for the HT29 cells was employed. Loading
of the tissue sections was performed in high K
+ solution [38]
containing 5 mM BCECF, 0.02% pluronic acid, 250 mM proben-
ecid and 0.1% BSA. Subsequently the tissue was washed in
Ringer’s solution containing 0.1% BSA and imaging of intracel-
lular pH was monitored. Since the tissue was more sensitive to
phototoxicity induced during the imaging, in the initial phase of
the experiment images were acquired every 10 s, while before the
addition of Na
+ the rate of acquisition was changed and an image
was acquired every 3 s. In each experimental group, the results are
the mean of at least 15 regions of interest from more than three
independent experiments from each animal. The rate of NHE
activity was calculated using a linear fit to the graph at the initial
50 s of this phase. The pHi calibration was performed using
nigericin as described above at pH of 6.6, 7, 7.5 and 8.2.
Statistical Analysis
Data are expressed as means 6 SEM. Each treatment was
compared with the control or Zn
2+ treatment, and statistical
significance between the groups was evaluated using the Student’s
t test or ANOVA followed by Tukey-Kramers test, as appropriate.
*, p,0.05; **, p,0.01.
Results
Zn
2+ enhances cell survival following exposure to
butyrate
We first asked if Zn
2+ can enhance survival of HT29 cells
exposed to the SCFA butyrate, known to trigger apoptotic
signaling in colon cancer cells [5]. The ZnR in HT29 cells was
briefly activated daily (80 mMZ n
2+, 10 min) during 3 consecutive
days, as previously described [21], and butyrate (30 mM, pH7.4,
for 24 h) was applied following the first application of Zn
2+. Cells
were then fixed and the number of cells was determined using the
SRB colorimetric assay (Fig. 1A). To determine if Zn
2+ enhances
cell growth we initially applied Zn
2+ to control cells not treated
with butyrate. Cell numbers were significantly higher (12167% of
the control cells) following the brief Zn
2+ treatment suggesting that
ZnR activation may enhance cell growth. Exposure of HT29 cells
to butyrate resulted in survival of only 3668% of the cells
compared to untreated cells, consistent with previous studies
[39,40]. However, 63611% of the cells survived when cells were
pre-treated with Zn
2+ (p,0.05 compared to butyrate alone,
Fig. 1A).
In order evaluate the involvement of ZnR in the enhanced
Zn
2+-dependent survival of HT29 cells, we used functional
desensitization of this receptor [22]. A procedure which does not
result in Zn
2+ permeation into the cells or in depletion of the Ca
2+
stores [22]. Cells were treated with 100 mMZ n
2+ for 15 min and
washed in Ringer’s solution for 30 min (desensitization protocol),
subsequent application of Zn
2+ did not induce the ZnR-dependent
Ca
2+ response in HT29 cells (right panel, Fig. 1B). Using the SRB
assay we first compared cell numbers between 1) cultures that were
treated with a brief application of Zn
2+ (such as used for ZnR
activation) subsequent to the desensitization procedure and 2) cells
that were desensitized and not re-activated by Zn
2+ (Fig. 1B, left
panel). Cell numbers were reduced following ZnR desensitization
compared to control cells which did not undergo the desensitiza-
tion protocol (approximately 75% of controls, Fig. 1B). This
suggests that ZnR activation, probably by residual Zn
2+ in the
growth medium, may be essential for cell growth. In contrast to
the effect of Zn
2+ on the control cells (Fig. 1A), following ZnR-
desensitization re-application of Zn
2+ did not change the number
of cells, suggesting that ZnR signaling is essential to mediate Zn
2+-
dependent cell growth. We then asked if ZnR activation would
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2+ reduces butyrate induced cell death and requires a functional ZnR. A. Cell numbers in cultures treated with
butyrate (30 mM, 24 h) were compared to control cultures (without butyrate, hatched bars) using the SRB colorimetric assay. Cells were treated daily
with Ringer’s solution (10 min) without (control) or with Zn
2+ (80 mMZ n
2+)n=6 ,* p ,0.05. B. The effect of Zn
2+ desensitization of ZnR (100 mMZ n
2+,
15 min) on cell growth was determined. 30 min following ZnR desensitization, Zn
2+ was re-applied to activate the ZnR as in A, or desensitized-cells
were treated with Ringer’s solution, and subsequently cell numbers were determined using the SRB assay. Following ZnR desensitization Zn
2+ did not
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desensitization was done prior to the daily activation of the ZnR,
and 24 h of butyrate treatment followed the first application of
Zn
2+ (as in A). As control, cells were maintained in Zn
2+-free
Ringer’s solution for the same time as the desensitized cells.
Following ZnR desensitization, numbers of cells treated with
butyrate only (2562%, Fig. 1C) were similar to those treated with
butyrate and Zn
2+ (2862%). Importantly, in the non-desensitized
cells Zn
2+ was still able to enhance cell survival (4261%, p,0.05,
Fig. 1C). Thus, desensitization and loss of ZnR activity eliminated
the pro-survival effect of Zn
2+ on butyrate-treated HT29 cells.
We then sought to determine if ZnR-dependent activation of
the PI3 and MAP kinase signaling is involved in enhancing cell
survival. We assessed Zn
2+-dependent ERK1/2 and AKT
phosphorylation in the presence of the MEK1/2 inhibitor
U0126, and the PI3K inhibitors wortmannin or LY294002
(Fig. 2A–B). We then studied if the effect of Zn
2+ on cell survival
is reversed by the inhibition of these pathways, using the lowest
concentration which effectively abolished ZnR-dependent Ca
2+
responses (Fig. 2C). The MEK1/2 inhibitor (U0126, 1 mM)
somewhat reversed the effect of Zn
2+ on cell survival, while PI3
kinase inhibition (wortmannin, 30 nM) largely eliminated the pro-
survival effect of Zn
2+ on HT29 cells exposed to butyrate. The
addition of both inhibitors resulted in a survival rate similar to that
of the cells treated with wortmannin alone. This indicates that
Zn
2+-dependent activation of ZnR and its downstream signaling,
largely via the PI3K, mediates the protective effects of Zn
2+ from
butyrate induced cell death.
ZnR/GPR39 mediates Zn
2+-dependent cell growth
GPR39, a putative candidate of ZnR, is expressed in several
tissues including the digestive tract. We therefore studied the effect
of GPR39 silencing on Zn
2+-dependent intracellular Ca
2+ release.
Transfection of HT29 cells with an siRNA construct designed to
silence GPR39 (siGPR39) significantly reduced GPR39 RNA level
and protein expression (Fig. 3A), followed by a dramatic reduction
of Zn
2+-dependent Ca
2+ rise (Fig. 3B). ATP-dependent Ca
2+
release in cells transfected with the siGPR39 or siControl
constructs were similar, indicating that the IP3 pathway is not
altered by GPR39 silencing. Next, we studied the effect of
silencing GPR39 expression on HT29 cell growth. Interestingly,
silencing GPR39 resulted in a slight decrease in cell numbers
compared to control cells (Fig. 3C). This ZnR/GPR39-dependent
cell growth is similar to that observed in the ZnR desensitized cells
(Fig. 1B). In contrast to the effect of Zn
2+ that enhanced HT29 cell
numbers in control cells (12167% of the control non-treated cells,
Fig. 1A), cell numbers were similar in the siGPR39-transfected
cells treated with Zn
2+ (67610%) or without it (75613%, Fig. 3C).
Thus, the results obtained in this set of experiments indicate that
GPR39 is mediating ZnR signaling in HT29 colonocytes and that
GPR39/ZnR signaling is required for normal cell growth.
GPR39 mediates ZnR signaling in colon epithelium
To identify the role of GPR39 in mediating Zn
2+-dependent
signaling in colonocytes we employed colon tissue from GPR39
KO mice. We have previously monitored Zn
2+-dependent
upregulation of Na
+/H
+ exchange (NHE) activity, which is
involved in recovery from acid load in colonocytes, but did not
determine the role of ZnR in mediating this effect [22]. While
essential for homeostatic cell maintenance, NHE activity may also
be relevant to survival of colonocytes from butyrate induced cell
death [41]. Mouse colon tissue was removed quickly and the tissue
was spread and glued with the epithelial side exposed and
immersed in high K
+ solution [22]. The tissue was loaded with
BCECF and mounted on a microscope holder allowing identifi-
cation of cells surrounding the crypts, low magnification and high
binning were used to minimize bleaching of the dye (inset Fig. 4B).
The NH4Cl paradigm was applied and pHi recovery rates
following intracellular acidification were determined (see Materials
and Methods). The rate of pHi recovery from the acid load,
representing NHE activity, was compared between Zn
2+ pre-
treated (100 mM, 2 min) and control (Zn
2+-free buffer) colon
tissue. Similar to the previously reported effect of Zn
2+ on NHE
activation, the rate of pHi recovery was enhanced by 3.760.6 fold
following Zn
2+ treatment in the GPR39 WT tissue (Fig. 4A). To
specifically address the role of GPR39 we compared the effect of
Zn
2+ on pH recovery in colon tissue obtained from GPR39 KO
mice. Application of Zn
2+ to GPR39 KO tissues did not enhance
the recovery rate compared to the controls (Fig. 4B).
The recovery rate from acid load in control (without Zn
2+)
GPR39 KO tissue was faster than that observed in the GPR39
WT tissue, likely due to a compensatory mechanism. Hence we
asked whether the recovery rate can be further upregulated in
GPR39 KO tissues. We have previously shown that prolonged
intracellular acidification activates NHE in HT29 cells, indepen-
dent of Zn
2+ treatment [22]. We therefore employed this paradigm
in colon tissue obtained from GPR39 KO mice. Tissue samples
loaded with BCECF were treated with NH4Cl as in Figure 4A,
and then washed with Na
+-free Ringer’s solution. When the cells
reached the acidic pH, instead of washing them with Na
+-
containing Ringer’s solution, they were maintained for 10 more
minutes with Na
+-free Ringer’s solution thereby achieving
prolonged intracellular acidification. Then Na
+-containing solu-
tion was applied and the pHi recovery rates were determined
(Fig. 4C). The prolonged acidification was followed by increased
recovery rate in the GPR39 KO tissues (260.2 fold compared to
controls), suggesting the exchanger activity is not saturated in the
knock-out tissue. Taken together with the fact that Zn
2+ did not
upregulate NHE activity in GPR39 KO colon tissue (Fig. 4B), this
supports our conclusion that ZnR/GPR39 is essential for Zn
2+-
dependent regulation of NHE activity.
The Na
+/H
+ exchanger mediates pHi recovery but not
survival following application of butyrate
Butyrate induces an acid load and triggers activation of NHE
[41]. To determine whether Zn
2+ enhances the rate of recovery of
intracellular pH we monitored changes of BCECF fluorescence in
butyrate treated HT29 cells. Application of 30 mM butyrate in
nominally Na
+-free Ringer’s solution, resulted in acidification of
the cells (Fig. 5A). Addition of Na
+ to the Ringer’s solution was
followed by slow recovery of pHi, consistent with a role for NHE
in reducing the acid load triggered by butyrate [42]. Rates of pHi
recovery were compared between cells pretreated with Zn
2+,
applied at concentration and duration sufficient to activate the
ZnR, and controls (Zn
2+-free Ringer’s solution). As shown in
Figure 5A, the rate of recovery was 7.160.01 fold higher in Zn
2+
enhance cell numbers significantly. Similarly, Ca
2+ release, monitored using Fura-2 fluorescence, in response to the re-application of Zn
2+ was almost
absent following desensitization of the ZnR (right panel). C. The effect of Zn
2+ on cell survival was determined following desensitization of ZnR
(100 mMZ n
2+, 15 min) or in controls (Ringer’s solution, 15 min), using the SRB assay. Cells were treated with butyrate and Zn
2+ was re-applied to
control cultures or cultures previously treated for ZnR desensitization (as indicated, see Methods). n=5, *p,0.05.
doi:10.1371/journal.pone.0035482.g001
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NHE1, the major isoform expressed in HT29 cells, we applied the
NHE1 inhibitor cariporide (0.5 mM). This was followed by a block
of both the Zn
2+-dependent and basal pHi recovery, indicating
that cellular pHi recovery is primarily mediated by NHE1 in
HT29 cells. We then asked if the signaling pathways activated by
ZnR are linked to the enhanced pHi recovery from butyrate acid
load. The rate of pHi recovery in cells that were pre-treated with
Figure 2. Inhibition of ZnR signaling reverses the pro-survival effects of Zn
2+. A–B. HT29 cells were treated with Zn
2+ for 10 min in Ringer’s
solution following 30–60 min incubation with the indicated concentrations of the MEK1/2 inhibitor U0126 or the PI3 kinase inhibitors wortmanin and
LY294002. Cell lysates were immunoblotted with an anti ERK1/2 or p-ERK1/2 (A), and with an anti-AKT or p-AKT (B). Desnitometry analyses are
presented, bottom panels, the results are normalized to the maximal activation obtained by the Zn
2+ treatment. n=3 *p,0.05 compared to control
and #p,0.05 compared to Zn
2+ treated cells. C. Cell numbers were determined in cells treated with butyrate and Zn
2+ in the presence or absence of
U0126 (1 mM), wortmannin (30 nM) or both. n=3 * p,0.05 compared to control and #p,0.05 compared to Zn
2+ treated cells.
doi:10.1371/journal.pone.0035482.g002
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2+ was attenuated
compared to the rate monitored in control cells (Fig. 5B–C). This
set of experiments indicates that ZnR activation via PI3 kinase
mediates Zn
2+-dependent upregulation of NHE activity.
Next we asked if Zn
2+ promotes cell survival by accelerating the
pHi recovery through activation of the NHE. Cells were treated
with the NHE1 inhibitor cariporide (0.5 mm), which completely
blocked the recovery from butyrate-induced acid load (Fig. 5C),
then butyrate and Zn
2+ were applied (as described in Fig. 1) and
cell survival was determined. Cell numbers following butyrate and
Zn
2+ treatment were similar in the presence or absence of
cariporide (Fig. 5D), suggesting that a different downstream
protein, and not NHE1 is linked to the pro-survival effects of Zn
2+
on HT29 cells.
Clusterin (CLU) is up-regulated by Zn
2+ acting via ZnR
The pro-survival protein clusterin (CLU) plays an important
role in promoting tumor cells proliferation and serves as a marker
for colon cancer [43]. We therefore studied the effect of butyrate
and Zn
2+ on CLU expression in colonocytes. HT29 cells were
treated with butyrate with or without Zn
2+, as described in Figure 1
(see also Materials and Methods). When applied alone, Zn
2+ did
not enhance CLU expression but butyrate induced an increase in
CLU expression compared to control cells (Fig. 6A). Treatment
with Zn
2+ and butyrate was followed by a further increase in CLU
expression level (55612% increase) compared to treatment with
butyrate only. Application of the cell impermeable Zn
2+ chelator,
CaEDTA (100 mM), in the presence of Zn
2+ and butyrate reversed
the increase of CLU expression, indicating that the rise in CLU
levels is induced by extracellular Zn
2+. We then sought to
determine the role of ZnR signaling in mediating the effects of
Zn
2+, using the MAPK (U0126, 1 mM) or PI3K (wortmannin,
30 nM) inhibitors. Application of each of these inhibitors
eliminated the stimulatory effect of Zn
2+ on CLU expression
(Fig. 6A). These results indicate that ZnR signaling is essential for
Zn
2+-dependent upregulation of CLU expression. To determine if
CLU expression is modulated by ZnR-dependent activation of
NHE1, HT29 cells were treated with Zn
2+ and butyrate in the
presence or absence of the NHE1 inhibitor. Cariporide (0.5 mm),
applied at a concentration that blocked ZnR-dependent activation
Figure 3. GPR39 mediates ZnR signaling and Zn
2+- dependent cell growth. A. Cells were transfected with siRNA sequences compatible to
GPR39 (siGPR39) or a scrambled sequence (siControl), and the mRNA and protein expression levels of GPR39 were monitored using Real-Time PCR
(top panel) and western-blot analysis (bottom panel). B. The Zn
2+ -dependent Ca
2+
i responses were monitored in cells transfected with siGPR39 or
siControl constructs using Fura-2 AM. ATP (50 mM) was subsequently applied to determine the integrity of the IP3 pathway. C. Cell numbers were
determined using the SRB method in cultures transfected with siGPR39 or controls, which were treated with or without Zn
2+ as in Figure 1A. n=3
*p,0.05.
doi:10.1371/journal.pone.0035482.g003
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2+-dependent upregulation
of CLU expression (Fig. 6B). Thus, Zn
2+ regulates CLU expression
via activation of ZnR signaling but independent of NHE1.
We next studied the role of CLU in mediating the ZnR-
dependent enhanced cell survival, HT29 cells were transfected
with an siRNA construct targeted to silence CLU expression
(siCLU). To assess the efficiency of CLU silencing we used western
blot analysis. Since basal levels of CLU monitored following
prolonged starvation in the non-transfected HT29 cells were low
(Fig. 6A) we treated transfected HT29 cells with serum-containing
medium for 24 h. Under these conditions CLU expression was
apparent and was significantly reduced by the siCLU (3863% of
siCont, Fig. 6C). Survival rates were then determined in the siCLU
transfected cells following butyrate and Zn
2+ treatment. Following
exposure to butyrate, survival rates of siCLU transfected cells were
similar to those of the control cells (5469% and 45610%,
respectively, Fig. 6D). However, no Zn
2+-dependent enhancement
of the survival was monitored in the siCLU transfected cells
(5467%). This indicates that Zn
2+ is inducing the pro-survival
effect on HT29 cells via upregulation of clusterin expression.
Figure 4. Zn
2+-dependent activation of NHE in the colon is mediated by GPR39. A–B. Colon epithelium was obtained from WT and GPR39
KO mice as described in Materials and Methods. Colonocytes were loaded with the intracellular pH-sensitive dye (BCECF, 5 mM) inset was imaged at
440 nm using a 106 objective, showing the cells surrounding crypts are loaded with the dye. The NH4Cl prepulse paradigm was employed to
determine NHE activity. Representative traces of the experiments from WT (A) and KO (B) tissues are shown in the left panels. In the right panels, the
bar graph represents the average rate of Na
+-dependent H
+ efflux following acidification as calculated from the traces, and the effect of Zn
2+ is
presented as a fold increase of the basal NHE activity (control). n=5, *p,0.05. C. The rate of Na
+-dependent H
+ efflux following acidification was
monitored in GPR39 KO tissues exposed to short acidification period (control) or a prolonged acidification (by maintaining a Na
+-free Ringer’s
solution for 10 min following initial acidification) and is presented as a fold increase of the Na/H exchange rate obtained in the short acidification.
Representative traces are shown in the left panel.N a
+/H
+ exchange activity was determined as the rate of pHi recovery, averaged rates are presented
in right panel.n=3 ,* p ,0.05.
doi:10.1371/journal.pone.0035482.g004
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moiety which mediates the pro-survival effects of ZnR. We first
studied the effect of GPR39 silencing on the Zn
2+-dependent
upregulation of CLU levels following butyrate treatment. Trans-
fection with the siRNA somewhat increased the basal CLU level in
control cells treated with Ringer’s solution only (Fig. 7A). In the
siGPR39 transfected cells, similar to non-transfected cells, butyrate
treatment upregulated CLU expression compared to the control
cells (Fig. 7A). In contrast to the non-transfected cells, Zn
2+ did not
increase CLU expression further in the siGPR39 transfected cells
(Fig. 7A). This result indicates that the effect of Zn
2+ on
upregulation of CLU is mediated by ZnR/GPR39. Next, we
studied the effect of silencing GPR39 expression on survival of
HT29 cells. Zn
2+ rescued HT29 cells transfected with a control
Figure 5. Zn
2+-dependent pHi recovery following butyrate induced acid load involves PI3K signaling, and activation of NHE1
isoform, but does not contribute to cell survival. A. The pH sensitive dye BCECF was used to monitor pHi in HT29 control cells, cells pretreated
with Zn
2+ (80 mM, 2 min) or cells treated with Zn
2+ and the NHE1 inhibitor cariporide (0.5 mM). Cells were superfused with 30 mM butyrate (pH 7.4) in
Na
+-free Ringer’s solution, and then Na
+ was added to the Ringer’s solution. Representative traces are shown. B. pHi was monitored following
application of butyrate and Zn
2+, as in A, in the presence of the PI3 kinase inhibitor (wortmannin). C. Averaged rates of pHi recovery following
addition of Na
+ as determined from the traces. n=3; *p,0.05. D. Cell survival of HT29 colonocytes was measured using the SRB assay. Cells were
treated with butyrate and Zn
2+, as in Figure 1, in the presence or absence of 0.5 mM cariporide. n=3; *p,0.05.
doi:10.1371/journal.pone.0035482.g005
ZnR/GPR39 Rescues Colonocytes from Butyrate
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2+ and butyrate upregulate the expression of the pro-survival protein clusterin (CLU). A. left panel: Immunoblot analysis
using anti a-CLU antibodies was done on lysates from HT29 cells treated with either Zn
2+, butyrate or both, in the presence or absence of the cell
impermeable Zn
2+ chelator CaEDTA, or the kinase inhibitors as indicated. right panel: Densitometeric analysis of a-CLU expression. n=3; *p,0.05. B.
left panel: Immunoblot of cell lysates from HT29 cells treated as in A in the presence or absence of cariporide (0.5 mM). right panel: Densitometeric
analysis of a-CLU expression. n=3 *p,0.05. C. CLU expression was monitored using westernblot analysis in HT29 cells transfected with an siCLU or
scrambled siRNA (Control) constructs. Using prolonged exposure time (180 s) CLU expression could be monitored in these cells. Actin was used as a
loading control. Right panel: Densitometry analysis of CLU expression level in control and siCLU transfected cells. D. Cells were transfected with an
siCLU construct and treated as in Figure 1, cell numbers were monitored using the SRB colorimetric assay and compared to control cells. n=3,
*p,0.05.
doi:10.1371/journal.pone.0035482.g006
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PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35482siRNA from butyrate induced cell death (Fig. 7B), similar to its
effect on the non-transfected HT29 cells (Fig. 1A). Exposure of the
siGPR39-transfected cells to butyrate with or without Zn
2+
treatment resulted in similarly low cell survival, 4267% and
39610% (respectively) of control cells not treated with butyrate
(Fig. 7B). Altogether, our data indicate that GPR39 is the ZnR,
and is mediating the effect of Zn
2+ on CLU expression leading to
enhanced cell survival.
Discussion
A role for extracellular Zn
2+ in activating major signaling
pathways linked to cellular proliferation and survival has been
previously demonstrated [44]. The aim of this study was to identify
the molecular moiety responsible for Zn
2+ signaling and determine
the physiological role of this pathway in promoting survival in the
unique acidic environment of the colon. Our results strongly
indicate that GPR39 is triggering ZnR signaling in colonocytes
and HT29 cells, as silencing of GPR39 completely abolished the
Zn
2+-dependent intracellular calcium release a hallmark of ZnR
activity. Interestingly, silencing of GPR39 was followed by a
decrease in basal cell growth, suggesting that even residual Zn
2+ in
the medium, via ZnR/GPR39, is sufficient to enhance cell growth.
Also, profound ZnR-dependent enhancement of NHE activity in
colonocytes obtained from WT mice was virtually eliminated in
colon tissue obtained from GPR39 KO mice. NHE transporters
are the major Na
+ influx pathway in the colon thereby regulating
solute transport [41,45,46], it will therefore be interesting to study
if the acute regulation of this pathway by Zn
2+ via ZnR/GPR39
may be linked to the antidiarrheal effects of zinc. Finally, our
results indicate that ZnR/GPR39 activation enhances survival of
colon cancer cells by rendering them less susceptible to cell death
induced by butyrate.
The presence of high concentration of SCFAs in the colon,
among them butyrate, generates a unique homeostatic environ-
ment that is essential for colonocytes nutrition but imposes an
acidic stress on these cells. Many studies have indicated that
butyrate is a major factor in selective colon tumor cell death,
acting via regulation of cell-cycle related proteins [47,48]. We
show that ZnR signaling affects the resistance of HT29 cells to
butyrate induced cell death. Our results indicate that Zn
2+-
dependent activation of the ZnR rescues HT29 colonocytes from
butyrate treatment. Butyrate has been suggested to reduce colon
cancer cell survival by inhibiting histone deacetylase activity [49].
Since histone deacetylase is a Zn
2+-dependent protein [50] it may
be argued that Zn
2+ can directly interfere with inhibition of
histone deacetylase by butyrate and thereby reverse the activity of
butyrate on cell survival. Our results do not support such scenario
since Zn
2+ permeation into colonocytes at the time intervals used
to trigger ZnR activity is minimal [22]. Hence it is unlikely that
Zn
2+, as applied in this study, affected histone deacytalse activity
but it was sufficient to enhance HT29 colonocyte survival.
Moreoever, molecular silencing of ZnR/GPR39 or desensitization
of the receptor reversed the protective effect of Zn
2+. Furthermore,
inhibition of the MAP and PI3 kinase pathways which are
activated by Zn
2+ via ZnR/GPR39 [22] also reversed the
protective effect of Zn
2+. These results are also consistent with
the ZnR-dependent enhanced prostate cancer cell survival that we
have shown previously [21].
Figure 7. GPR39/ZnR mediates Zn
2+-dependent activation of the pro-survival protein, CLU, and rescues cells from butyrate induced
cell death. A. HT29 cells transfected with an siGPR39 construct, were treated with butyrate or without it (Ringer’s solution alone), in the presence or
absence of Zn
2+ (as described in Fig. 1). Cell lysates were subjected to immunoblotting with an anti-a-CLU, actin levels are presented as control.
Densitometry analysis of the results is shown in the right panel, normalized to anti-a-CLU expression level in control (non-transfected) cells treated
with Ringer’s solution (100%). n=3. B. The siGPR39 cells or controls were treated with butyrate with or without Zn
2+ as described in Figure 1. Cells
were then fixed and number of cells was monitored using the SRB colorimetric assay, gray line indicates cell numbers in butyrate only treated
siGPR39-transfected cells. n=3; *p,0.05.
doi:10.1371/journal.pone.0035482.g007
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PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e35482Based on the key role of Na
+/H
+ exchange in regulating pHi
and reducing acid load, we reasoned that this pathway may be
involved in the rescue of HT29 colonocytes from butyrate.
Inhibition of NHE indeed abolished the ZnR-dependent
enhanced pHi recovery from the acid load induced by butyrate.
Despite the documented role of NHE in cell survival [51,52] the
Zn
2+-dependent activation of NHE did not enhance survival rates
of HT29 cells following administration of butyrate, indicating that
a distinct mechanism is mediating the effect of Zn
2+ on cell
survival. It should be noted that colonocytes are chronically
exposed to SCFA-induced acid load that can overwhelm the
ability of NHE to trigger effective pHi recovery and thus these cells
may have a different mechanism to enhance cell survival. We have
previously shown that prolonged acidification, independently of
Zn
2+, upregulates NHE activity [22] and may regulate intracel-
lular pH during the prolonged acid load. In accordance, butyrate
may exert a pro-apoptotic effect that is independent of the
acidification [53,54], and thus ZnR-dependent activation of anti-
apoptotic pathways will be a critical event for the rescue of the cells
by zinc. Indeed, we show that Zn
2+, via ZnR/GPR39, induces
expression of clusterin in cells exposed to butyrate. Clusterin has a
well-documented anti-apoptotic effect, which is of clinical
importance in enhancing the resistance of tumor cells to a large
variety of pro-apoptotic stimuli [55]. Clusterin expression was
linked both to cell death or survival, numerous studies indicate that
the nuclear (nCLU, 65 kDa) or the secreted (sCLU, 40 kDa)
isoforms of this protein have distinct roles, such that sCLU is
linked to cell survival while nCLU is associated with cell death
[56]. Hence, the increased expression of sCLU induced by Zn
2+
suggests that this pathway is enhancing cell survival. Inhibition of
Zn
2+-dependent clusterin induction by MEK inhibitors further
supports an anti-apoptotic effect for Zn
2+. This pathway
participates, for example, in enhancing a pro-survival effect
following ionizing radiation treatment via IGF-1R activation
[57]. Increase in secreted clusterin levels, triggered via the PI3K
pathway activation, was associated with chemoresistance of
prostate cancer cells [58]. Consistent with this effect, our results
show that ZnR-dependent sCLU expression requires activation of
AKT, further suggesting a survival role for the ZnR-dependent
pathway. While extracellular Zn
2+ via the ZnR is shown to
promote cell survival, an opposing role is suggested for
intracellular Zn
2+ rise that often leads to cell death
[59,60,61,62,63]. Interestingly, upregulation of the pro-apoptotic
nCLU form by ischemia, which is known to induce a rise in
intracellular Zn
2+, has been shown to play a role in neuronal death
[64,65]. Consistent with such a role, intracellular Zn
2+ or Cd
2+ rise
induces expression of the pro-apoptotic nCLU and triggers
testicular germ cells death [66]. Interestingly, previous works have
also suggested that intracellular Zn
2+ rise following prolonged
exposure to this ion, may result in colon cancer cell death [67].
Thus, we suggest that while intracellular Zn
2+ enhances the
expression of nCLU and induces cell death, extracellular Zn
2+
activates the ZnR/GPR39 signaling pathway and induces the
expression of sCLU leading to enhanced survival.
In conclusion, our data indicate the ZnR links between Zn
2+
and clusterin, a major player in colonocyte survival or apoptosis
[68]. By enhancing clusterin expression Zn
2+, via the ZnR, renders
HT29 cells less susceptible to pro-apoptotic agents in the digestive
tract and may be of importance in digestive system function and
disease.
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